Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 196


Chemically Active, Porous 3D-Printed Thermoplastic Composites.

Evans KA, Kennedy ZC, Arey BW, Christ JF, Schaef HT, Nune SK, Erikson RL.

ACS Appl Mater Interfaces. 2018 May 2;10(17):15112-15121. doi: 10.1021/acsami.7b17565. Epub 2018 Mar 2.


3D-printed poly(vinylidene fluoride)/carbon nanotube composites as a tunable, low-cost chemical vapour sensing platform.

Kennedy ZC, Christ JF, Evans KA, Arey BW, Sweet LE, Warner MG, Erikson RL, Barrett CA.

Nanoscale. 2017 May 4;9(17):5458-5466. doi: 10.1039/c7nr00617a.


IGF-II induced by hepatitis B virus X protein regulates EMT via SUMO mediated loss of E-cadherin in mice.

Ha HL, Kwon T, Bak IS, Erikson RL, Kim BY, Yu DY.

Oncotarget. 2016 Aug 30;7(35):56944-56957. doi: 10.18632/oncotarget.10922.


Plk1-mediated stabilization of 53BP1 through USP7 regulates centrosome positioning to maintain bipolarity.

Yim H, Shin SB, Woo SU, Lee PC, Erikson RL.

Oncogene. 2017 Feb 16;36(7):966-978. doi: 10.1038/onc.2016.263. Epub 2016 Aug 1.


Reagent-free and portable detection of Bacillus anthracis spores using a microfluidic incubator and smartphone microscope.

Hutchison JR, Erikson RL, Sheen AM, Ozanich RM, Kelly RT.

Analyst. 2015 Sep 21;140(18):6269-76. doi: 10.1039/c5an01304f.


Induction of G1 Arrest by SB265610 Involves Cyclin D3 Down-regulation and Suppression of CDK2 (Thr160) Phosphorylation.

Goda AE, Erikson RL, Ahn JS, Kim BY.

Anticancer Res. 2015 Jun;35(6):3235-43.


Synthesis and antitumor activity of natural compound aloe emodin derivatives.

Thimmegowda NR, Park C, Shwetha B, Sakchaisri K, Liu K, Hwang J, Lee S, Jeong SJ, Soung NK, Jang JH, Ryoo IJ, Ahn JS, Erikson RL, Kim BY.

Chem Biol Drug Des. 2015 May;85(5):638-44. doi: 10.1111/cbdd.12448. Epub 2014 Nov 5.


Preclinical evaluation of bortezomib/dipyridamole novel combination as a potential therapeutic modality for hematologic malignancies.

Goda AE, Erikson RL, Sakai T, Ahn JS, Kim BY.

Mol Oncol. 2015 Jan;9(1):309-22. doi: 10.1016/j.molonc.2014.08.010. Epub 2014 Sep 6.


Molecular basis for unidirectional scaffold switching of human Plk4 in centriole biogenesis.

Park SY, Park JE, Kim TS, Kim JH, Kwak MJ, Ku B, Tian L, Murugan RN, Ahn M, Komiya S, Hojo H, Kim NH, Kim BY, Bang JK, Erikson RL, Lee KW, Kim SJ, Oh BH, Yang W, Lee KS.

Nat Struct Mol Biol. 2014 Aug;21(8):696-703. doi: 10.1038/nsmb.2846. Epub 2014 Jun 29.


Plk1-targeted therapies in TP53- or RAS-mutated cancer.

Yim H, Erikson RL.

Mutat Res Rev Mutat Res. 2014 Mar 12. pii: S1383-5742(14)00019-2. doi: 10.1016/j.mrrev.2014.02.005. [Epub ahead of print]


Hierarchical recruitment of Plk4 and regulation of centriole biogenesis by two centrosomal scaffolds, Cep192 and Cep152.

Kim TS, Park JE, Shukla A, Choi S, Murugan RN, Lee JH, Ahn M, Rhee K, Bang JK, Kim BY, Loncarek J, Erikson RL, Lee KS.

Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):E4849-57. doi: 10.1073/pnas.1319656110. Epub 2013 Nov 25.


A derivative of chrysin suppresses two-stage skin carcinogenesis by inhibiting mitogen- and stress-activated kinase 1.

Liu H, Hwang J, Li W, Choi TW, Liu K, Huang Z, Jang JH, Thimmegowda NR, Lee KW, Ryoo IJ, Ahn JS, Bode AM, Zhou X, Yang Y, Erikson RL, Kim BY, Dong Z.

Cancer Prev Res (Phila). 2014 Jan;7(1):74-85. doi: 10.1158/1940-6207.CAPR-13-0133. Epub 2013 Oct 29.


Structural basis for the dephosphorylating activity of PTPRQ towards phosphatidylinositide substrates.

Yu KR, Kim YJ, Jung SK, Ku B, Park H, Cho SY, Jung H, Chung SJ, Bae KH, Lee SC, Kim BY, Erikson RL, Ryu SE, Kim SJ.

Acta Crystallogr D Biol Crystallogr. 2013 Aug;69(Pt 8):1522-9. doi: 10.1107/S0907444913010457. Epub 2013 Jul 19.


A chrysin derivative suppresses skin cancer growth by inhibiting cyclin-dependent kinases.

Liu H, Liu K, Huang Z, Park CM, Thimmegowda NR, Jang JH, Ryoo IJ, He L, Kim SO, Oi N, Lee KW, Soung NK, Bode AM, Yang Y, Zhou X, Erikson RL, Ahn JS, Hwang J, Kim KE, Dong Z, Kim BY.

J Biol Chem. 2013 Sep 6;288(36):25924-37. doi: 10.1074/jbc.M113.464669. Epub 2013 Jul 25.


STK295900, a dual inhibitor of topoisomerase 1 and 2, induces G(2) arrest in the absence of DNA damage.

Kim SO, Sakchaisri K, Thimmegowda NR, Soung NK, Jang JH, Kim YS, Lee KS, Kwon YT, Asami Y, Ahn JS, Erikson RL, Kim BY.

PLoS One. 2013;8(1):e53908. doi: 10.1371/journal.pone.0053908. Epub 2013 Jan 22. Erratum in: PLoS One. 2013;8(6): 10.1371/annotation/c5f432f6-1e92-42c0-8727-7ae972215d6f. N R, Thimmegowda [corrected to Thimmegowda, N R].


Essential role of Cenexin1, but not Odf2, in ciliogenesis.

Chang J, Seo SG, Lee KH, Nagashima K, Bang JK, Kim BY, Erikson RL, Lee KW, Lee HJ, Park JE, Lee KS.

Cell Cycle. 2013 Feb 15;12(4):655-62. doi: 10.4161/cc.23585. Epub 2013 Jan 23.


Osteoporosis regulation by salubrinal through eIF2α mediated differentiation of osteoclast and osteoblast.

He L, Lee J, Jang JH, Sakchaisri K, Hwang J, Cha-Molstad HJ, Kim KA, Ryoo IJ, Lee HG, Kim SO, Soung NK, Lee KS, Kwon YT, Erikson RL, Ahn JS, Kim BY.

Cell Signal. 2013 Feb;25(2):552-60. doi: 10.1016/j.cellsig.2012.11.015. Epub 2012 Nov 23.


Metabolic stress controls mTORC1 lysosomal localization and dimerization by regulating the TTT-RUVBL1/2 complex.

Kim SG, Hoffman GR, Poulogiannis G, Buel GR, Jang YJ, Lee KW, Kim BY, Erikson RL, Cantley LC, Choo AY, Blenis J.

Mol Cell. 2013 Jan 10;49(1):172-85. doi: 10.1016/j.molcel.2012.10.003. Epub 2012 Nov 8.


Regulation of CEP131 gene expression by SP1.

Huong PT, Soung NK, Jang JH, Cha-Molstad HJ, Sakchaisri K, Kim SO, Jang JM, Kim KE, Lee KS, Kwon YT, Erikson RL, Ahn JS, Kim BY.

Gene. 2013 Jan 15;513(1):75-81. doi: 10.1016/j.gene.2012.10.074. Epub 2012 Nov 5.


Crystal structure of xenotropic murine leukaemia virus-related virus (XMRV) ribonuclease H.

Kim JH, Kang S, Jung SK, Yu KR, Chung SJ, Chung BH, Erikson RL, Kim BY, Kim SJ.

Biosci Rep. 2012 Oct;32(5):455-63. doi: 10.1042/BSR20120028.


Identification of 3-acyl-2-phenylamino-1,4-dihydroquinolin-4-one derivatives as inhibitors of the phosphatase SerB653 in Porphyromonas gingivalis, implicated in periodontitis.

Jung SK, Ko Y, Yu KR, Kim JH, Lee JY, Chae CH, Ji S, Kim CH, Lee HK, Choi EB, Kim BY, Erikson RL, Chung SJ, Kim SJ.

Bioorg Med Chem Lett. 2012 Mar 1;22(5):2084-8. doi: 10.1016/j.bmcl.2012.01.011. Epub 2012 Jan 21.


Patulin induces colorectal cancer cells apoptosis through EGR-1 dependent ATF3 up-regulation.

Kwon O, Soung NK, Thimmegowda NR, Jeong SJ, Jang JH, Moon DO, Chung JK, Lee KS, Kwon YT, Erikson RL, Ahn JS, Kim BY.

Cell Signal. 2012 Apr;24(4):943-50. doi: 10.1016/j.cellsig.2011.12.017. Epub 2011 Dec 30.


A self-propelled biological process: Plk1-dependent, product-activated feedforward mechanism.

Park EJ, Erikson RL, Lee KS.

Cell Cycle. 2011 Oct 15;10(20):3411-2. doi: 10.4161/cc.10.20.17522. No abstract available.


Regulation of microtubule-based microtubule nucleation by mammalian polo-like kinase 1.

Johmura Y, Soung NK, Park JE, Yu LR, Zhou M, Bang JK, Kim BY, Veenstra TD, Erikson RL, Lee KS.

Proc Natl Acad Sci U S A. 2011 Jul 12;108(28):11446-51. doi: 10.1073/pnas.1106223108. Epub 2011 Jun 20.


Asperlin induces G₂/M arrest through ROS generation and ATM pathway in human cervical carcinoma cells.

He L, Nan MH, Oh HC, Kim YH, Jang JH, Erikson RL, Ahn JS, Kim BY.

Biochem Biophys Res Commun. 2011 Jun 10;409(3):489-93. doi: 10.1016/j.bbrc.2011.05.032. Epub 2011 May 12.


Feed-forward mechanism of converting biochemical cooperativity to mitotic processes at the kinetochore plate.

Park JE, Erikson RL, Lee KS.

Proc Natl Acad Sci U S A. 2011 May 17;108(20):8200-5. doi: 10.1073/pnas.1102020108. Epub 2011 Apr 27.


Proteasome inhibitor-I enhances tunicamycin-induced chemosensitization of prostate cancer cells through regulation of NF-κB and CHOP expression.

Huong PT, Moon DO, Kim SO, Kim KE, Jeong SJ, Lee KW, Lee KS, Jang JH, Erikson RL, Ahn JS, Kim BY.

Cell Signal. 2011 May;23(5):857-65. doi: 10.1016/j.cellsig.2011.01.010. Epub 2011 Jan 27.


Crystal structure of constitutively monomeric E. coli Hsp33 mutant with chaperone activity.

Chi SW, Jeong DG, Woo JR, Lee HS, Park BC, Kim BY, Erikson RL, Ryu SE, Kim SJ.

FEBS Lett. 2011 Feb 18;585(4):664-70. doi: 10.1016/j.febslet.2011.01.029. Epub 2011 Jan 23.


Cell division cycle 6, a mitotic substrate of polo-like kinase 1, regulates chromosomal segregation mediated by cyclin-dependent kinase 1 and separase.

Yim H, Erikson RL.

Proc Natl Acad Sci U S A. 2010 Nov 16;107(46):19742-7. doi: 10.1073/pnas.1013557107. Epub 2010 Nov 1.


Polo-like kinase 1 depletion induces DNA damage in early S prior to caspase activation.

Yim H, Erikson RL.

Mol Cell Biol. 2009 May;29(10):2609-21. doi: 10.1128/MCB.01277-08. Epub 2009 Mar 16.


Plk1 depletion in nontransformed diploid cells activates the DNA-damage checkpoint.

Lei M, Erikson RL.

Oncogene. 2008 Jun 26;27(28):3935-43. doi: 10.1038/onc.2008.36. Epub 2008 Feb 25.


Mechanisms of mammalian polo-like kinase 1 (Plk1) localization: self- versus non-self-priming.

Lee KS, Park JE, Kang YH, Zimmerman W, Soung NK, Seong YS, Kwak SJ, Erikson RL.

Cell Cycle. 2008 Jan 15;7(2):141-5. Epub 2007 Oct 16.


Finding Plk3.

Zimmerman WC, Erikson RL.

Cell Cycle. 2007 Jun 1;6(11):1314-8. Epub 2007 Jun 11. Review.


Polo-like kinase 3 is required for entry into S phase.

Zimmerman WC, Erikson RL.

Proc Natl Acad Sci U S A. 2007 Feb 6;104(6):1847-52. Epub 2007 Jan 30.


The nuclear localization signal of mitotic kinesin-like protein Mklp-1: effect on Mklp-1 function during cytokinesis.

Liu X, Erikson RL.

Biochem Biophys Res Commun. 2007 Feb 23;353(4):960-4. Epub 2006 Dec 28.


Ectopic expression of Plk1 leads to activation of the spindle checkpoint.

Tang J, Erikson RL, Liu X.

Cell Cycle. 2006 Nov 1;5(21):2484-8. Epub 2006 Sep 12.


Checkpoint kinase 1 (Chk1) is required for mitotic progression through negative regulation of polo-like kinase 1 (Plk1).

Tang J, Erikson RL, Liu X.

Proc Natl Acad Sci U S A. 2006 Aug 8;103(32):11964-9. Epub 2006 Jul 27.


A mammalian NudC-like protein essential for dynein stability and cell viability.

Zhou T, Zimmerman W, Liu X, Erikson RL.

Proc Natl Acad Sci U S A. 2006 Jun 13;103(24):9039-44. Epub 2006 Jun 5.


Normal cells, but not cancer cells, survive severe Plk1 depletion.

Liu X, Lei M, Erikson RL.

Mol Cell Biol. 2006 Mar;26(6):2093-108.


Monitoring the cell cycle by multi-kinase-dependent regulation of Swe1/Wee1 in budding yeast.

Lee KS, Asano S, Park JE, Sakchaisri K, Erikson RL.

Cell Cycle. 2005 Oct;4(10):1346-9. Epub 2005 Oct 22. Review.


CCT chaperonin complex is required for the biogenesis of functional Plk1.

Liu X, Lin CY, Lei M, Yan S, Zhou T, Erikson RL.

Mol Cell Biol. 2005 Jun;25(12):4993-5010.


Molecular interactions of Polo-like-kinase 1 with the mitotic kinesin-like protein CHO1/MKLP-1.

Liu X, Zhou T, Kuriyama R, Erikson RL.

J Cell Sci. 2004 Jul 1;117(Pt 15):3233-46. Epub 2004 Jun 15.


The MAP kinase pathway is required for entry into mitosis and cell survival.

Liu X, Yan S, Zhou T, Terada Y, Erikson RL.

Oncogene. 2004 Jan 22;23(3):763-76.


Role of Plk2 (Snk) in mouse development and cell proliferation.

Ma S, Charron J, Erikson RL.

Mol Cell Biol. 2003 Oct;23(19):6936-43.


Polo-like kinase 1 in the life and death of cancer cells.

Liu X, Erikson RL.

Cell Cycle. 2003 Sep-Oct;2(5):424-5. Review.


A role for Plk1 phosphorylation of NudC in cytokinesis.

Zhou T, Aumais JP, Liu X, Yu-Lee LY, Erikson RL.

Dev Cell. 2003 Jul;5(1):127-38.


Polo-like kinase (Plk)1 depletion induces apoptosis in cancer cells.

Liu X, Erikson RL.

Proc Natl Acad Sci U S A. 2003 May 13;100(10):5789-94. Epub 2003 May 5.


Phosphorylation of threonine 210 and the role of serine 137 in the regulation of mammalian polo-like kinase.

Jang YJ, Ma S, Terada Y, Erikson RL.

J Biol Chem. 2002 Nov 15;277(46):44115-20. Epub 2002 Aug 30.

Supplemental Content

Loading ...
Support Center